[HTML][HTML] Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
The risks of miRNA therapeutics: in a drug target perspective
S Zhang, Z Cheng, Y Wang, T Han - Drug design, development …, 2021 - Taylor & Francis
RNAi therapeutics have been growing. Patisiran and givosiran, two siRNA-based drugs,
were approved by the Food and Drug Administration in 2018 and 2019, respectively …
were approved by the Food and Drug Administration in 2018 and 2019, respectively …
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
Acute myeloid leukemia (AML) is driven by leukemia stem cells (LSCs) that resist
conventional chemotherapy and are the major cause of relapse,. Hypomethylating agents …
conventional chemotherapy and are the major cause of relapse,. Hypomethylating agents …
[PDF][PDF] DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis
Epigenetic modifications, including DNA methylation, represent a potential mechanism for
environmental impacts on human disease. Maternal smoking in pregnancy remains an …
environmental impacts on human disease. Maternal smoking in pregnancy remains an …
DNA methylation profiles in cancer diagnosis and therapeutics
Y Pan, G Liu, F Zhou, B Su, Y Li - Clinical and experimental medicine, 2018 - Springer
Cancer initiation and proliferation is regulated by both epigenetic and genetic events with
epigenetic modifications being increasingly identified as important targets for cancer …
epigenetic modifications being increasingly identified as important targets for cancer …
[HTML][HTML] circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family
L Chen, S Zhang, J Wu, J Cui, L Zhong, L Zeng, S Ge - Oncogene, 2017 - nature.com
Circular RNAs (circRNAs) represent a class of non-coding RNAs that are widely expressed
in mammals. However, it is largely unknown about the function of human circRNAs and the …
in mammals. However, it is largely unknown about the function of human circRNAs and the …
[HTML][HTML] The role of epigenetics in autoimmune/inflammatory disease
AEA Surace, CM Hedrich - Frontiers in immunology, 2019 - frontiersin.org
Historically, systemic self-inflammatory conditions were classified as either autoinflammatory
and caused by the innate immune system or autoimmune and driven by adaptive immune …
and caused by the innate immune system or autoimmune and driven by adaptive immune …
MicroRNAs in cancer
G Di Leva, M Garofalo, CM Croce - Annual Review of Pathology …, 2014 - annualreviews.org
MicroRNAs (miRNAs) are small noncoding RNAs that typically inhibit the translation and
stability of messenger RNAs (mRNAs), controlling genes involved in cellular processes such …
stability of messenger RNAs (mRNAs), controlling genes involved in cellular processes such …
A decade of exploring the cancer epigenome—biological and translational implications
The past decade has highlighted the central role of epigenetic processes in cancer
causation, progression and treatment. Next-generation sequencing is providing a window …
causation, progression and treatment. Next-generation sequencing is providing a window …
[HTML][HTML] Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia
Acute myeloid leukemia (AML) is a malignant tumor of the immature myeloid hematopoietic
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …